Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

IL-10 polymorphisms +434T/C, +504G/T, and -2849C/T may predispose to tubulointersititial nephritis and uveitis in pediatric population

  • Sari Rytkönen,

    Roles Conceptualization, Investigation, Writing – original draft

    Affiliation PEDEGO Research Unit and Medical Research Center (MRC), University of Oulu and Oulu University Hospital, Oulu, Finland

  • Jarmo Ritari,

    Roles Formal analysis, Writing – review & editing

    Affiliation Clinical Laboratory, Finnish Red Cross Blood Service, Helsinki, Finland

  • Juha Peräsaari,

    Roles Formal analysis, Writing – review & editing

    Affiliation Clinical Laboratory, Finnish Red Cross Blood Service, Helsinki, Finland

  • Ville Saarela,

    Roles Conceptualization, Writing – review & editing

    Affiliation Ville Saarela, Department of Ophthalmology, Oulu University Hospital, Finland

  • Matti Nuutinen,

    Roles Conceptualization, Supervision, Writing – review & editing

    Affiliation PEDEGO Research Unit and Medical Research Center (MRC), University of Oulu and Oulu University Hospital, Oulu, Finland

  • Timo Jahnukainen

    Roles Conceptualization, Funding acquisition, Supervision, Writing – review & editing

    timo.jahnukainen@hus.fi

    Affiliation Timo Jahnukainen, Department of Pediatric Nephrology and Transplantation, New Children’s Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

Abstract

Background

Tubulointerstitial nephritis (TIN) and uveitis syndrome (TINU) are likely to be autoimmune diseases. Based on previous studies, adults with isolated idiopathic uveitis have polymorphisms in interleukin 10 (IL-10) and tumor necrosis factor α (TNF-α) genes. We aimed to evaluate the presence of IL-10 and TNF-α polymorphisms in a nationwide cohort of pediatric TIN/TINU patients.

Methods

Single nucleotide polymorphisms in IL-10 (+434T/C, +504G/T, -1082G/A, -2849C/T) and in TNFα (-308G/A, -238G/A, -857C/T) genes were genotyped in 30 well-defined pediatric patients with idiopathic TIN/TINU syndrome. Control group frequencies for these SNPs were obtained from 393 independent Finnish subjects.

Results

The homozygous minor allele in IL-10 +434T (rs2222202) and IL-10+504G (rs3024490) was found in all patients with TIN or TINU syndrome while the frequency of these minor alleles in the control population was 44% and 23%, respectively (p <0.001). In IL-10 SNP -2849 (rs6703630) a significant difference was found with genotype TT in all patients (p = 0.004) and in subgroups with TINU syndrome (p = 0.017) and TINU syndrome with chronic uveitis (p = 0.01) compared to reference population. There were no statistical differences in any of the studied TNF-α genotypes between TIN/TINU patients and control population.

Conclusions

A significant difference in the frequency of IL-10+434T and +504G alleles was found between TIN/TINU patients and control population. Genotype -2849TT was more frequently present in patients with TINU syndrome than in the reference subjects. Genetic variation in the inflammatory mediators may predispose to autoimmune nephritis and uveitis.

Introduction

Tubulointerstitial nephritis (TIN) is a relatively rare but significant cause of acute renal insufficiency (AKI) among children and adults [1]. It is an inflammatory disease, possibly of autoimmune origin [25], primarily affecting the renal interstitium and tubular wall without significant glomerular or vascular involvement [6,7]. It can sometimes be accompanied by uveal inflammation (TINU syndrome) which is typically anterior and bilateral [8, 9].

TIN may be triggered by several causes including infections and medications, or etiology can be idiopathic [10]. TIN and uveitis separately can also be associated with systemic immunologic conditions such as sarcoidosis, systemic lupus erythematosus (SLE) or inflammatory bowel disease (IBD) [1113]. Previous studies have shown evidence of polymorphisms in interleukin 10 (IL-10) and tumor necrosis factor α (TNF-α) coding genes in patients with non-infectious uveitis (NIU) [14, 15]. There are also recent data showing that polymorphisms in these two inflammatory regulators are enriched in patients with inflammatory bowel disease and children with wheezing [1619]. In this study, the aim was to investigate the frequency of IL-10 and TNF-α single nucleotide polymorphisms (SNPs) in a national cohort of well-defined children and adolescents with TIN/ TINU syndrome compared to Finnish reference population.

Materials and methods

The study was approved by the Ethics Committee of Helsinki University Hospital and followed the tenets of the Declaration of Helsinki. Written informed consent was obtained from all patients and/or parents before the study commenced.

This study was part of our previous nationwide study evaluating HLA associations in TIN/TINU patients [9, 20] and the patient demographics has been reported before. Briefly, the inclusion criteria were biopsy-proven TIN in pediatric patients under 16 years of age. The study cohort was collected from all five university hospitals in Finland between 2008 and 2011. Meticulous work-up was done to exclude possible underlying conditions, such as drug-induced TIN, respiratory infection, sarcoidosis, connective tissue disorder and lymphoma. Uveitis was classified according to standardization of uveitis nomenclature (SUN) criteria. All patients were followed up by a pediatric nephrologist and ophthalmologist for at least one year after the diagnosis of TIN [9, 20, 21].

A total of 30 patients were enrolled (17 boys, 13 girls). Nineteen patients (63%) had uveitis (TINU syndrome) and 15 (50%) of them had chronic uveitis. The median age at the time of diagnosis was 12.5 (9.4–14.7) years. Demographic data is presented in Table 1.

thumbnail
Table 1. Patient demographics and key laboratory findings at the time of the diagnostic biopsy.

Data is presented for all patients and for males and females separately.

https://doi.org/10.1371/journal.pone.0211915.t001

The targeted single nucleotide polymorphisms from our TIN patient cohort were IL-10 +434T/C, +504G/T, -1082G/A, -2849C/T and TNF-α -308G/A, -238G/A, -857C/T. The primers used in polymerase chain reaction (PCR) to amplify DNA fragments containing our SNPs of interest are presented in Table 2. Genomic DNA samples were sequenced in Oulu University DNA sequencing core facility laboratory with the following method: The PCR amplifications were carried out in a total volume of 11μL, which contained 20 ng genomic DNA, 25 mM MgCl2, 2 mM dNTP mix, 5 μM of each primer, 0.4 unit Maxima Hot Start Taq DNA polymerase and 1 x Hot Start PCR Buffer (Fermentas). PCR products were screened using QIA excel Advanced System (QIAGEN) to confirm the successful amplification. Agencourt AMPure protocol (Beckman Coulter) was used to purify PCR products for sequencing. Finally, the samples were sequenced using ABI3500xL Genetic Analyzer and BigDye Terminator vs.1.1 reagents (Life Technologies). Chromatograms were analyzed by using the Chromas Lite 2.1 program.

thumbnail
Table 2. Primers used in polymerase chain reaction to amplify DNA fragments.

https://doi.org/10.1371/journal.pone.0211915.t002

The frequency of these SNPs was analyzed in the whole study population and in the subgroups of patients with TIN, TINU and TINU with chronic uveitis. Control group (n = 686) frequencies for the IL-10 and TNF-α SNP were obtained from both Illumina Immunochip [22] analysis of 587 Finnish siblings and from the 1000 Genomes Project Finnish population subset (n = 99) [23]. The Immunochip hybridization and genotype calling were performed at the Institute for Molecular Medicine Finland (Helsinki, Finland) according to manufacturer’s instructions. Since the TNF-α SNP -857 / rs1799724 and IL-10 SNP -2849 / rs6703630 were not included in the Immunochip array, their frequencies were imputed using Impute2 v3.2.3 software [24] with default settings and 1000GP_Phase3 as the reference data set. The imputed sequence intervals in GRCh37 Human genome build were 206000000–208000000 for chromosome 1 (rs6703630) and 30500000–32600000 for chromosome 6 (rs1799724).

Statistical analysis

Statistical analyses were carried out with R v3.2.2 (R Core Team 2015). Fisher’s exact test was performed for significance of association for SNP frequencies between patients and controls. The reference SNP frequencies used in Fisher’s test were weighted by the respective sample sizes from the Immunochip (n = 587) and 1000 Genomes (n = 99) data sets. Since the Immunochip data consisted of sibling pairs, the sample size number used in Fisher’s test was halved to take into account the fact that relatedness reduces the effective sample size. Logistic regression was performed for SNP genotype association using the Immunochip sibling cohort as a reference. Finally, all raw p-values were adjusted for multiple testing by the Bonferroni method.

Results

The homozygous minor allele in IL-10 +434T (rs2222202) and IL-10+504G (rs3024490) was found in all patients with TIN/TINU syndrome (Table 3). The frequency of these minor alleles in the control population was 44% and 23%, respectively (p <0.001). The presence of minor allele in IL-10 -2849T did not differ significantly between the cases and the controls (p = 0.33) (Table 3). However, the homozygous -2849TT genotype was found more frequently (p = 0.004) in the patients (17%) than in the controls (0.01%) (Table 4). There were no statistical differences in any of the studied TNF-α alleles between TIN/TINU patients and control population (Table 3, S1 Table).

thumbnail
Table 3. Distribution of alleles in single nucleotide polymorphisms between study population and control subjects.

The genotypes frequencies are presented in TIN/U patients.

https://doi.org/10.1371/journal.pone.0211915.t003

thumbnail
Table 4. Significant differences in IL-10 minor alleles and genotypes between study cohort and control population.

Data is presented for all patients and depending on the presence and chronicity of uveitis.

https://doi.org/10.1371/journal.pone.0211915.t004

In the subgroup analysis, a significant increase in the allele frequency of IL-10+434T (rs2222202) was found in patients with isolated nephritis (p <0.001), TINU syndrome (p <0.001) and TINU with chronic uveitis (p <0.001) when compared to the reference population (Table 4). IL-10+504G (rs3024490) minor allele was present more often in TINU patients (p = 0.004) but not in subgroups with isolated TIN (p = 0.5) or TINU syndrome with chronic uveitis (p = 0.07) (Table 4).

In SNP -2849 (rs6703630) a significant difference in genotype frequency TT was found in patients with TINU syndrome (p = 0.017) and TINU syndrome with chronic uveitis (p = 0.01) when compared to the reference population (Table 4).

Discussion

In the present study, we aimed to investigate the frequency of IL-10 and TNF-α polymorphisms in a cohort of Finnish pediatric patients with idiopathic TIN/TINU syndrome. All patients with either isolated nephritis or TINU syndrome were homozygous carriers of the IL-10 +434T and +504G minor alleles, which suggests that these SNPs may predispose to TIN and/or TINU. In addition to IL-10 +434T and +504G minor alleles, the patients with uveitis and chronic uveitis had significantly more frequently IL-10 -2849TT genotype than Finnish control population. Despite the high occurrence of uveitis in the present study population, none of the previously reported TNF-α SNPs -308G/A, -238G/A, -857C/T were found in this cohort. Our results suggest that IL-10 polymorphisms may have a role in susceptibility to TIN/TINU while genetic variation in TNF-α gene may be connected to isolated uveitis.

It is obvious that tendency for uveitis with or without tubulointerstitial nephritis is dependent on genetic factors. We, among others, have previously shown an association between HLA haplotypes and uveitis and/or TIN [2, 3, 25, 26]. Based on our present findings, variability in the IL-10 gene may predispose to TIN/TINU in pediatric population. IL-10 production is stimulated by various exogenous and endogenous factors, but it has also been shown to be under genetic control with association to different SNPs in several independent studies [2729]. Different allele and genotype variations alter cytokine profiles influencing the development and severity of various diseases, as documented in SLE, tuberculosis and several other infectious diseases (IL-10 overexpression) [3036], and rheumatoid arthritis and asthma (IL-10 downregulation) [19, 3739]. Polymorphisms in inflammatory response regulating genes have been reported among patients with uveitis [4042]. Atan et al. have previously shown a significant association between IL-10–2849, +434, +504 minor allele frequencies and non-infectious uveitis (NIU) in a cohort of 192 patients [14]. The SNPs +434 (rs2222202) and +504 (rs3024490) located in introns are in regulatory regions, and may influence the expression of mRNA and/or protein. The same point is related to SNP-2849 (rs6703630) located in the 5'UTR region. According to the Genotype-Tissue Expression (GTEx) database (https://gtexportal.org), IL-10 mRNA expression is increased significantly in whole blood samples from human subjects with minor allele SNPs +434 (rs2222202), +504 (rs3024490), and -2849 (rs6703630). This data indicates, that these homozygous minor alleles have impact on gene regulation separately, however, their cooperative action and influence on IL-10 level remain unclear.

In the present study, previously reported, association between TNF-α alleles -308AA and -238AA, IL-10 SNP -1082AA and TIN/TINU could not be found [14, 15]. All patients, including those with chronic uveitis, had -238GG and -308GG genotype, which suggests that in TIN patients the studied genetic variation in TNF-α does not have any influence on uveitis risk. The genetic background in TIN/TINU patients is probably different from patients with isolated uveitis. This is also supported by our previous finding in this same study population showing that none of the patients had the HLA-DRB1*15 genotype, which has been suggested to be associated with increased risk for uveitis [43, 44] and is relatively common in the Finnish population (15%) [3]. It is also likely, that the association between HLA genotype as well as genetic variation in cytokine genes and uveitis appear to depend on study population and ethnicity [45]. In previous studies, the patient cohorts have been rather heterogeneous consisting of patients with varying causes of uveitis, such as sarcoidosis, Bechet’s disease, sympathetic ophthalmia, intermediated uveitis, white dots with or without inflammation, and the age range of the patients was wide. [14, 15]. In the present study, all patients had biopsy proven nephritis and systemic diseases and infectious agents were excluded. In addition, the patients were prospectively followed-up by pediatrician and ophthalmologist at least 12 months from initial diagnosis, which is likely to improve the reliability of our findings. It is also of note that in the present study, all patients had TIN and approximately half of them had chronic uveitis. The presence of nephritis has not been reported in majority of the previous studies.

The major caveat of the study is the relatively small study population. TIN/TINU is a relatively rare entity. We have collected patients from all university hospitals in Finland and this is one of the largest pediatric data that has been published. In addition, all patients were evaluated carefully and followed up prospectively using the same protocol. Another weakness is that we did not measure serum levels of IL-10 and TNF-α, and therefore based on our data, we are not able to draw any conclusions about the clinical relevance of the identified SNPs in this study population.

In conclusion, IL-10 gene polymorphisms +434T/C, +504G/T, and genotype -2849TT were found in a majority of the TIN/TINU patients while the frequency of none of the previously reported TNFα SNPs differed from control population. The clinical importance of this finding remains to be studied.

Supporting information

S1 Table. Clinical information and TNFa -308, TNFa -238, TNFa -857, IL10–2849, IL10–1082, IL10 +434, IL10 +504 genotype of each patient.

https://doi.org/10.1371/journal.pone.0211915.s001

(XLSX)

Acknowledgments

The authors thank Mari Taipale from the DNA Sequencing and Expression Analysis Center, Biocenter Oulu, University of Oulu, for executing the sequencing of the patient samples.

References

  1. 1. Greising J, Trachtman H, Gauthier B, Valderrama E. Acute interstitial nephritis in adolescents and young adults. Child Nephrol Urol 1990;10: 189–195. pmid:2088589
  2. 2. Levinson RD, Park MS, Rikkers SM, et al. Strong associations between specific HLA-DQ and HLA-DR alleles and the tubulointerstitial nephritis and uveitis syndrome. Invest Ophthalmol Vis Sci. 2003;44: 653–657. pmid:12556395
  3. 3. Peräsaari J, Saarela V, Nikkilä J, et al. HLA associations with tubulointerstitial nephritis with or without uveitis in Finnish pediatric population: a nation-wide study. Tissue Antigens. 2013;81: 435–441. pmid:23594347
  4. 4. Reddy AK, Hwang YS, Mandelcorn ED, Davis JL. HLA-DR, DQ class II DNA typing in pediatric panuveitis and tubulointerstitial nephritis and uveitis. Am J Ophthalmol. 2014;157: 678-686.e671-672.
  5. 5. Rytkönen SH, Kulmala P, Autio-Harmainen H, et al. FOXP3+ T cells are present in kidney biopsy samples in children with tubulointerstitial nephritis and uveitis syndrome. Pediatr Nephrol. 2018;33: 287–293. pmid:28894974
  6. 6. Ellis D, Fried WA, Yunis EJ, Blau EB. Acute interstitial nephritis in children: a report of 13 cases and review of the literature. Pediatrics. 1981;67: 862–870. pmid:7015263
  7. 7. Takemura T, Okada M, Hino S, et al. Course and outcome of tubulointerstitial nephritis and uveitis syndrome. Am J Kidney Dis. 1999;34: 1016–1021. pmid:10585310
  8. 8. Mandeville JT, Levinson RD, Holland GN. The tubulointerstitial nephritis and uveitis syndrome. Surv Ophthalmol. 2001;46: 195–208. pmid:11738428
  9. 9. Saarela V, Nuutinen M, Ala-Houhala M, Arikoski P, Rönnholm K, Jahnukainen T. Tubulointerstitial nephritis and uveitis syndrome in children: a prospective multicenter study. Ophthalmology. 2013; 120: 1476–1481. pmid:23511116
  10. 10. Praga M & González E. Acute interstitial nephritis. Kidney Int. 2010;77: 956–961. pmid:20336051
  11. 11. Coutant R, Leroy B, Niaudet P, et al. A Renal granulomatous sarcoidosis in childhood: a report of 11 cases and a review of the literature. Eur J Pediatr 1999;158: 154–159. pmid:10048615
  12. 12. Oikonomou K, Kapsoritakis A, Eleftheriadis T, Stefanidis I, Potamianos S. Renal manifestations and complications of inflammatory bowel disease. Inflamm Bowel Dis. 2011;17: 1034–1045. pmid:20842645
  13. 13. Pagni F, Galimberti S, Galbiati E, et al. Tubulointerstitial lesions in lupus nephritis: International multicentre study in a large cohort of patients with repeat biopsy. Nephrology (Carlton). 2016;21: 35–45.
  14. 14. Atan D, Fraser-Bell S, Plskova J, et al. Cytokine polymorphism in noninfectious uveitis. Invest Ophthalmol Vis Sci. 2010;51: 4133–4142. pmid:20335604
  15. 15. Atan D, Heissigerova J, Kuffová L, et al. Tumor necrosis factor polymorphisms associated with tumor necrosis factor production influence the risk of idiopathic intermediate uveitis. Mol Vis. 2013;19: 184–195. pmid:23378732
  16. 16. Amre DK, Mack DR, Morgan K, et al. Interleukin 10 (IL-10) gene variants and susceptibility for paediatric onset Crohn's disease. Aliment Pharmacol Ther. 2009;29: 1025–1031. pmid:19210299
  17. 17. Bilolikar H, Nam AR, Rosenthal M, Davies JC, Henderson DC, Balfour-Lynn IM. Tumour necrosis factor gene polymorphisms and childhood wheezing. Eur Respir J. 2005;26: 637–646. pmid:16204594
  18. 18. Ferguson LR, Huebner C, Petermann I, et al. Single nucleotide polymorphism in the tumor necrosis factor-alpha gene affects inflammatory bowel diseases risk. World J Gastroenterol. 2008;14: 4652–4661. pmid:18698679
  19. 19. Korppi M, Nuolivirta K, Lauhkonen E, et al. P IL-10 gene polymorphism is associated with preschool atopy and early-life recurrent wheezing after bronchiolitis in infancy. Pediatr Pulmonol. 2017;52: 14–20. pmid:27228545
  20. 20. Jahnukainen T, Ala-Houhala M, Karikoski R, et al. Clinical outcome and occurrence of uveitis in children with idiopathic tubulointerstitial nephritis. Pediatr Nephrol. 2011;26: 291–299. pmid:21120539
  21. 21. Jahnukainen T, Saarela V, Arikoski P, et al. Prednisone in the treatment of tubulointerstitial nephritis in children. Pediatr Nephrol. 2013;28: 1253–1260. pmid:23605375
  22. 22. Cortes A & Brown MA. Promise and pitfalls of the Immunochip. Arthritis Res Ther. 2011;13:101 pmid:21345260
  23. 23. 1000 Genomes Project Consortium, Abecasis GR, Altshuler D, Auton A, et al. A map of human genome variation from population-scale sequencing. Nature. 2010;467: 1061–1073. pmid:20981092
  24. 24. Howie B, Marchini J, Stephens M. Genotype imputation with thousands of genomes. G3 (Bethesda). 2011;1: 457–470.
  25. 25. Mackensen F, David F, Schwenger V, et al. HLA-DRB1*0102 is associated with TINU syndrome and bilateral, sudden-onset anterior uveitis but not with interstitial nephritis alone. Br J Ophthalmol 2011;95: 971–975. pmid:21059595
  26. 26. Márquez A, Cordero-Coma M, Martín-Villa JM, et al. New insights into the genetic component of non-infectious uveitis through an Immunochip strategy. J Med Genet 2017;54: 38–46. pmid:27609017
  27. 27. Rees LE, Wood NA, Gillespie KM, Lai KN, Gaston K, Mathieson PW. The interleukin-10-1082 G/A polymorphism: allele frequency in different populations and functional significance. Cell Mol Life Sci. 2002;59: 560–569. pmid:11964134
  28. 28. Reuss E, Fimmers R, Kruger A, Becker C, Rittner C, Höhler T. Differential regulation of interleukin-10 production by genetic and environmental factors—a twin study. Genes Immun. 2002;3: 407–413. pmid:12424622
  29. 29. Westendorp RG, Langermans JA, Huizinga TW, et al. Genetic influence on cytokine production and fatal meningococcal disease. Lancet. 1997;349: 170–173. pmid:9111542
  30. 30. Abdallah E, Waked E, Abdelwahab MA. Evaluating the association of interleukin-10 gene promoter -592 A/C polymorphism with lupus nephritis susceptibility. Kidney Res Clin Pract 2016;35: 29–34. pmid:27069855
  31. 31. Barnes PF, Lu S, Abrams JS, Wang E, Yamamura M, Modlin RL () Cytokine production at the site of disease in human tuberculosis. Infect Immun. 1993;61: 3482–3489. pmid:8335379
  32. 32. Gröndal G, Gunnarsson I, Rönnelid J, Rogberg S, Klareskog L, Lundberg I. Cytokine production, serum levels and disease activity in systemic lupus erythematosus. Clin Exp Rheumatol. 2000;18: 565–570. pmid:11072595
  33. 33. Llorente L, Richaud-Patin Y, Wijdenes J, et al. Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus. Eur Cytokine Netw. 1993;4: 421–427. pmid:8186374
  34. 34. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001;19: 683–765. pmid:11244051
  35. 35. Van der Poll T, Marchant A, Keogh CV, Goldman M, Lowry SF. Interleukin-10 impairs host defense in murine pneumococcal pneumonia. J Infect Dis 1996;174: 994–1000. pmid:8896500
  36. 36. Verbon A, Juffermans N, Van Deventer SJ, Speelman P, Van Deutekom H, Van der Poll T. Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment. Clin Exp Immunol 1999;115: 110–113. pmid:9933428
  37. 37. Antoniv TT, Ivashkiv LB. Dysregulation of interleukin-10-dependent gene expression in rheumatoid arthritis synovial macrophages. Arthritis Rheum. 2006;54: 2711–272. pmid:16947381
  38. 38. Fathy MM, Elsaadany HF, Ali YF et al. Association of IL-10 gene polymorphisms and susceptibility to Juvenile Idiopathic Arthritis in Egyptian children and adolescents: a case-control study. Ital J Pediatr: 2017. pmid:28257625
  39. 39. Zheng XY, Guan WJ, Mao C, et al. Interleukin-10 promoter 1082/-819/-592 polymorphisms are associated with asthma susceptibility in Asians and atopic asthma: a meta-analysis. Lung. 2014;192: 65–73. pmid:24162871
  40. 40. Ewald L, Beate LW, Stephanie S, Wilfried R, Yosuf e-S. Analysis of a Functional IL-6 Gene Polymorphism in HLAB27 Associated and Intermediate Uveitis Gives New Insight in Disease Pathogenesis and Commonality with Other Autoimmune Diseases. J Immunol Res. 2015:174062 pmid:26640809
  41. 41. Li H, Hou S, Yu H, et al. Association of Genetic Variations in TNFSF15 With Acute Anterior Uveitis in Chinese Han. Invest Ophthalmol Vis Sci. 2015;56: 4605–4610. pmid:26200500
  42. 42. Lindner E, Weger M, Ardjomand N, Renner W, El-Shabrawi Y () Associations of Independent IL2RA Gene Variants with Intermediate Uveitis. PLoS One. 2015;10: e0130737. pmid:26133380
  43. 43. Raja SC, Jabs DA, Dunn JP, et al. Pars planitis: clinical features and class II HLA associations. Ophthalmology 1999;106: 594–599. pmid:10080220
  44. 44. Tang WM, Pulido JS, Eckels DD, Han DP, Mieler WF, Pierce K. The association of HLA-DR15 and intermediate uveitis. Am J Ophthalmol 1997;123: 70–75. pmid:9186099
  45. 45. Clive DM, Vanguri VK. The syndrome of tubulointerstitial nephritis with uveitis (TINU). Am J Kidney Dis 2018;72: 118–128. pmid:29429748